Class 4 Medicines Defect Information: Morningside Healthcare Limited, Tramadol Hydrochloride 50 Mg Capsules & Tramadol Hydrochloride Morningside 50 Mg Prolonged-release Capsules, El(24)a/57
Tramadol Recall Summary Morningside Healthcare Limited has recalled two batches of tramadol capsules (batch MRA2303 of the prolonged-release 50 mg version and batch MRF2301 of the standard 50 mg version) due to a packaging defect. The recall affects patients in the United Kingdom who received these specific batches. This is classified as a Class III defect, meaning the packaging issue could potentially cause problems but is not expected to result in serious health consequences.
- Recalling firm
- Morningside Healthcare Limited
- Reason
- Morningside Healthcare Limited has informed the MHRA of a packaging issue identified in batch MRA2303 of Tramadol Hydrochloride Morningside 50 mg Prolonged-Release Capsules and batch MRF2301 of Tramadol Hydrochloride 50 mg Capsules.
- Classification
- Class III
- Category
- drug recall
- Country
- United Kingdom
- Agency
- UK Medicines and Healthcare products Regulatory Agency
- Recall date
- 2024-11-27
- Status
- Ongoing
- Distribution
- United Kingdom
Official recall notice from UK Medicines and Healthcare products Regulatory Agency
Recall details on Nibble Recalls: https://trynibble.app/recalls/27e99304-7753-4a77-a91c-540f5838814e